CAR T-Cells: The Creation of a “Living Drug” to Treat Pediatric Leukemia
At the end of this session, learners will be able to understand the process, architecture, manufacture, and trials of chimeric antigen receptor (CAR) T-cells. Speaker:…
At the end of this session, learners will be able to understand the process, architecture, manufacture, and trials of chimeric antigen receptor (CAR) T-cells. Speaker:…